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Objectives: The aim of the present study was to evaluate the effect of two different dosages of
alendronate on induced orthodontic movement in an experimental model involving rats
with osteoporosis following ovariectomy.
Design: Female Wistar rats (Rattus norvegicus) eight weeks of age were divided into four
groups (n = 12/group): ovariectomized (OVX group); ovariectomized and treated with alen-
dronate sodium at 1 mg/kg (Group OVX + ALN1); ovariectomized and treated with alendro-
nate sodium at 2 mg/kg (Group OVX + ALN2); and sham operated (control). Three months
after ovariectomy, the maxillary right first molar was submitted to movement for five and
seven days. After the death of the animals, the maxilla were removed and processed for
microscopic evaluation. The maxillary left first molar (without movement) was used for
comparison purposes in all groups. The samples were processed for the quantification of
alveolar bone and tooth movement.
Results: Intragroup comparisons showed significant movement after five and seven days
(p < 0.05) for all groups. Comparison among groups revealed greater tooth movement in the
OVX group (p < 0.05), on day 7.
Conclusions: Both alendronate sodium doses similarly decreased tooth movement in ovari-
ectomized rats (p > 0.05). Movement in ovariectomized + alendronate groups were also
smaller than non-ovariectomized rats, however without statistical difference.
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Orthodontic treatment has become more accessible to the
population and a greater number of adults currently seek such
treatment. As a consequence, orthodontists are more likely to
have patients with systemic diseases stemming from the
ageing process, such as osteoporosis. The correction of
malocclusions in such patients requires knowledge on the
influence of orthodontic movement on bone tissue and teeth.
Osteoporosis causes the loss of bone mass in long bones
and vertebrae. This condition can also alter the bone tissue of
the maxilla and mandible involved in tooth movement during
orthodontic treatment.1,2 Systemic drugs used to treat
osteoporosis can have an effect on orthodontic treatment
by acting on osteogenesis and structures of the period-
ontium.3,4
Bisphosphonates are among the indicated medications for
the treatment of osteopenic and osteoporotic states.5 The
amino-bisphosphonate alendronate sodium (ALN) is one of
the most widely used medications for this purpose due to its
high potential for inhibiting bone resorption.6,7 ALN has a
strong affinity for circulating calcium and to mineral at bone
surfaces8 and inhibits enzyme activity in osteoclasts, thereby
impeding the dissolution of bone tissue and the degradation of
collagen.8 Upon being transported with isolated components
of bone tissue through the cytoplasm of osteoclasts, ALN
induces biochemical events capable of initiating apoptosis in
these cells.9–11 Thus, bisphosphonates contribute to control-
ling bone turnover and preventing osteopenia/osteoporosis.
Case reports involving patients submitted to prolonged
bisphosphonate treatment describe lower rates of tooth
movement, which hampers orthodontic treatment.12,13 How-
ever, further evidence is needed to determine the extent to
which altered bone metabolism in patients under systemic
treatment for osteopenia and osteoporosis affects tooth
movement.3,4,14
The experimental ovariectomy is an important study
model that evaluates, in animals, the consequences of loss
of bone mass in several situac¸o˜es,14 since it is increasingly
frequent presence of individuals with frames of osteopenia
and osteoporosis under treatment with alendronate sodium
in dental offices.
In humans, the recommended dose of alendronate is 1 mg/
kg body weight, once a week, however there is no consensus
regarding the appropriate dosage for animal testing. There-
fore, the aim of this work was evaluate the effect of two
different dosages of alendronate on induced orthodontic
movement in an experimental model involving rats with
osteoporosis following ovariectomy.
2. Materials and methods
The procedures employed in this study were approved by the
Ethics Committee on Animal Experimentation under process
number 2011-03696.
Forty-eight female Wistar rats (Rattus norvegicus) aged eight
weeks were used. The animals were anesthetized with an
intramuscular injection of xylazine 8 mg/kg (AnasedanAgribrands do Brasil Ltda, Paulı´nia, Sa˜o Paulo, Brazil) and
ketamine 70 mg/kg (Dopalen Sespo Industria e Comercio Ltda,
Jacareı´, Sa˜o Paulo, Brazil) prior to bilateral laparotomy for the
removal of the ovaries. The animals were divided into four
groups (n = 12/group): ovariectomized (OVX group); ovariecto-
mized and treated with 1 mg/kg or 2 mg/kg alendronate
sodium salt (DEG ‘‘Importation of Chemical Products’’, India)
diluted in saline solution (Group OVX + ALN1 and Group
OVX + ALN2); and a sham operated group used as the control.
Throughout the experiment, the animals were kept in an
animal lodging facility with a 12-h light/dark cycle at a
temperature of 20 8C and free access to ration and water.
For 90 days following ovariectomy, the OVX + ALN1 and
ALN2 groups received a subcutaneous injection of ALN at
respective doses, twice a week on non-consecutive days.15
After three months, the animals were anesthetized with an
intramuscular injection of 8 mg/kg xylazine and 70 mg/kg
ketamine prior to the placement of a mechanical device for the
induction of tooth movement. For such, the appliance
designed by Heller and Nanda (1979) 16 was modified with
the replacement of the steel spring with a nickel-titanium
spring (Sentalloy, GAC, New York, USA) and a light-curing
resin in the cervical region of the incisor to enhance the
retention of the wire. The appliance was anchored on the
upper incisors and right first molar to produce the mesializa-
tion of the molar.14 The upper right first molar was wrapped
with steel wire measuring 0.20 mm in diameter (Morelli,
Sorocaba, Sa˜o Paulo, Brazil) and attached to the spring
measuring 3 mm in length for the application of a continuous
force of 50 cN.17–19 The spring was tied in a cervical position to
the resin (Z100, 3M, Saint Paul, MN, USA) of the upper right
incisor with steel wire measuring 0.25 mm in diameter
(Morelli, Sorocaba, Sa˜o Paulo, Brazil) (Fig. 1).
The animals in all four groups were euthanized with an
overdose of ketamine five and seven days (n = 6 animals/
group/evaluation time) following the placement of the
orthodontic appliance.20,21 The upper left first molar, which
was not submitted to movement, was used for comparison
purposes in each group. On induced tooth movement in rats,
the initial resorptive phenomena are the first three days, with
its peak at 5 days and its consequences markedly present at 7
days.22 From the viewpoint of optical microscopy, the analysis
of the effects of the forces three days before or after seven days
do not bring significant results because they do not cover
the main tissue and cellular phenomena of induced tooth
movement.15
All animals were weighed at the beginning and end of the
experiment (Table 1). The maxillae were removed, dissected,
immersed in a 10% formalin solution for 48 h, washed in
running water for 24 h and decalcified in 18% EDTA solution
for six weeks. The specimens were then dehydrated, cleared
and embedded in paraffin. Semi-serial cuts measuring 7 mm
were made in the longitudinal direction along the larger axis of
the molars and stained with haematoxylin and eosin.
For the histomorphometric analysis, the histological cuts
were examined under an optical microscope (BX41, Olympus,
Tokyo, Japan) coupled to a digital camera (QColor3, Olympus,
Tokyo, Japan) and photographed. Measures were performed
with the aid of the Image Pro Plus1 program, version 4.5
(Media Cybernetics, USA).
Fig. 1 – Mechanical device with nickel–titanium spring
anchored to right upper incisor to obtain mesialization of
upper first molar in female Wistar rat.
a r c h i v e s o f o r a l b i o l o g y 6 0 ( 2 0 1 5 ) 7 7 6 – 7 8 1778For the analysis of the distance of movement and
quantification of interradicular alveolar bone, two cuts per
slide were selected on three slides per animal per evaluation
time. To quantify the movement of the first molar, images of
the cuts of the first and second molars were captured with an
objective of 4 for measurement of the smallest distance
between the distal face of the first molar and mesial face of the
second molar. For such, three measures were performed andTable 1 – Comparisons for weight (mean W SD) among groups (
1 mg/kg – OVX + ALN1, 2 mg/kg alendronate sodium – OVX + A
Mean weight (g) of animals per group
Baseline 30
CONTROL (n = 6) 216a  18 260
OVX (n = 6) 217a  21 289
OVX + ALN1 (n = 6) 211a  15 281
OVX + ALN2 (n = 6) 215a  16 283
Lower case letters refer to statistical comparisons in columns. Different 
5% significance level ( p < 0.05)).
Fig. 2 – Microscopic cut of maxilla of female Wistar rat. (A) Illustr
M1 and M2 represent three measures of intertooth distance (H&
molar; outline represents limit established between mesial and
original magnification: 2T).the two largest were discarded (Fig. 2A). The results were
expressed as mean (mm)  standard deviation.
For the quantification of alveolar bone tissue, histological
cuts were captured with an 2 objective. The bone located
between mesial and distal root of the upper first molar was
selected for analysis. The total bone area (area occupied by
maxillary alveolar bone and cavities filled with hematopoietic
tissue) between the alveolar crest and the middle third of the
roots was delimiting by tracing the bone bordering of
periodontal ligament (Fig. 2B). For determination of the area
occupied exclusively by bone tissue, the bone cavities were
measured summed and the result was subtracted from the
total area. The results were expressed as percentage values
(the proportion of area occupied by bone tissue in relation to
the total area).
2.1. Statistical analysis
The data were analyzed with the aid of the GraphPad Prism R
3.1 program. Parametric one-way analysis of variance
(ANOVA) was employed, with the level of significance set to
5% ( p < 0.05).
3. Results
Table 1 displays rats weight (mean + SD) for all groups. In
general, animals increased weight with time. At 60 and 90control, ovariectomized – OVX, ovariectomized treated with
LN2) at baseline and at 30, 60 and 90 days.
 days 60 days 90 days
a  22 267a  14 289a  25
a  28 302b  31 331b  35
a  17 292a,b  18 316a,b  25
a  25 296a,b  13 309a,b  32
letters are statistically significant (ANOVA and Tukey post hoc test at
ating upper first (M1) and second (M2) molars; bars between
E, original magnification: 4T). (B) Illustrating upper first
 distal root; arrow indicates direction of force applied (H&E,
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controls (Table 1).
Table 2 shows the mean distance between the first and
second molars for all groups at the different evaluation times
compared to the side without movement. Intragroup compar-
isons showed significant movement after five and seven days
(p < 0.05) for all groups. Comparison among groups revealed
greater tooth movement in the OVX group (p < 0.05), on day 7.
Table 3 displays the percentage of interradicular alveolar
bone. The highest and lowest percentages of bone tissue were
found in the control group and OVX group, respectively
(p < 0.05). After five days no differences were found among
groups. After 7 days interradicular bone percentage in OVX
was significantly lower (p < 0.05) compared to other groups
(Table 3).
4. Discussion
The molars of Wistar rats (Rattus norvegicus) is the most widely
used experimental model in research on induced tooth
movement.14,16,23 This model also allows assessing changes
in bone tissue stemming from systemic disorders and the
medications used for treatment.15 Murine molars do no
exhibit continuous rhizogenesis. This characteristic and the
favourable root morphology allow the extrapolation of the
results to humans, notwithstanding the inherent limitations
of all animal models.24
The magnitude of the force applied in the experiments for
the murine MDI molar ranges from 0.8 cN25 to 100 cN26 in
order to evaluate the supporting tissues and the amount of
tooth movement. This study employed a magnitude 50 cN
of force by means of a spring NiTi within the range
recommended by the literature.21 This super-elastic springTable 2 – Comparison of the distances between first and seco
ovariectomized – OVX, ovariectomized treated with 1 mg/kg – O
the side without orthodontic movement and on the side subm
Intertooth distance (mm)
Control OV
Without movement 287a,A  22 265a,A
Day 5 386b,A  60 393b,A
Day 7 398b,A  41 462b,B
Lower case letters refer to statistical comparisons in columns (without m
rows (groups). Different letters are statistically significant (ANOVA and T
Table 3 – Percentages (mean W SD) comparisons of upper first
ovariectomized – OVX, ovariectomized treated with 1 mg/kg – O
the side without orthodontic movement and on the side subm
Percentage of interradicular bone
Control OV
Without movement 88.6a  1.6 78.5b 
Day 5 80.1a  3.1 76.1a 
Day 7 82.7a  1.3 77.3b 
Lower case letters refer to statistical comparisons in rows. Different lett
significance level ( p < 0.05)).has the ability to release a constant magnitude force without
decline, regardless of the stretching performed, performing18
forces for prolonged periods without interruption.27,28 Ren
et al.21 reported that many investigations of tooth movement
in rats apply heavy forces. Those heavy forces may cause
hyalinization and movement retardation. Although 50 cN
applied in the present study can be considered a heavy force
for rat molar, all groups received this same standardized
force, so this fact did not seem to affect our group
comparisons. Ren et al.21 recommended less than 10 cN for
rat molar, which can be particularly determinant for
periodontal responses and/or root resorption evaluations,
not included in the present study.
Ovariectomy simulates the loss of bone mass stemming
from oestrogen depletion, thereby mimicking postmeno-
pausal osteoporosis.23,29 Three months following ovary
removal, a significant loss of bone mass is found in the
femur of rats.23 Moreover, after two to three months, the
maxilla of rats is also significantly affected.30,31 The literature
reports that oestrogen depletion is related to an increase in
food intake and weight in rodents.32,33 This increase in weight
stemming from hyperphagia caused by ovariectomy occurs in
both lean mass and fatty tissue.32 Thus, the success of
ovariectomy in reducing ovarian hormones in the present
study can be assessed by the change in body mass, as a
significant increase in weight occurred in the animals
submitted to ovariectomy in comparison to the sham-
operated group after 60 and 90 days (Table 1). Jee and Yao34
discussed that experimental phase, in ovariectomy models
for osteoporosis in rats, should start at least at 6 months of
age, as bone mass achieves its peak at this time. In the present
study, tooth movement started after 5 months, but we
registered significant differences in bone loss among groups,
even before bone mass peak. Thus, despite our study designnd molar (mean W SD) among the groups (control,
VX + ALN1, 2 mg/kg alendronate sodium – OVX + ALN2) on
itted to movement for five and seven days.
X OVX + ALN1 OVX + ALN2
 16 260a,A  17 258a,A  21
 66 366b,A  59 364b,A  51
 68 373b,A  45 369b,A  67
ovement, day 5 and day 7), while upper case letters for comparison in
ukey post hoc test at 5% significance level ( p < 0.05)).
 molar interradicular bone among groups (control,
VX + ALN1, 2 mg/kg alendronate sodium – OVX + ALN2) on
itted to movement for five and seven days.
X OVX + ALN1 OVX + ALN2
 3.2 83.4a,b  1.5 84.5a,b  2.5
 1.5 80.3a  1.2 80.9a  1.8
 2.6 84.3a  0.7 84.5a  1.9
ers are statistically significant (ANOVA and Tukey post hoc test at 5%
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justified faster movement in OVX group.
In the present study, all groups exhibited progressively
greater movement at five and seven days ( p < 0.05). However,
this movement was greatest in the ovariectomized rats that
did not receive ALN, with a statistically significant difference
in comparison to the other groups at day 7 ( p < 0.05). The
suppression of oestrogen production caused an approximate
10% loss in interradicular alveolar bone three months
following ovariectomy, suggesting that this mineral loss is
responsible for the greater tooth movement in the ovariecto-
mized rats that did not received ALN.
Alendronate is highly effective in preventing bone loss
associated with the absence of endogenous oestrogen and
inducing a sustained increase in bone mass during treatment
in animals. Likewise, ALN promotes the recovery of mineral
density in humans due to its inhibitory action on osteoclasts.35
With the remodelling process in balance, osteoclastic activity
is diminished with no direct effect on the formation of new
bone tissue.36 It is likely that this reduction in osteoclastic
activity accounts for the lesser tooth movement found in the
OVX + ALN1 and ALN2 groups in comparison to the OVX group
(Table 2).
The standardized dosages in the present study were based
on the most common commercial brands and clinical trials
involving alendronate, which indicate one or two 70-mg pills
per week (1–2 mg/kg weekly). As the metabolic index of rats is
approximately twofold faster than in humans, the same doses
of 1 mg/kg and 2 mg/kg were employed, but administered
twice weekly.15 The rats began treatment immediately
following ovariectomy and both doses of ALN proved
effectiveness in controlling mineral loss, with similar move-
ment to that found in the sham-operated control group
(Table 2). Comparing these two dosages in a previous study37
for femur evaluation in ovarectomized rats, 2 mg/kg sodium
alendronate caused significant improvement in bone percen-
tages compared to the 1 mg/kg dosage. The results motivated
us to check orthodontic movement vis a vis the two dosages.
But in the present study we found no significant difference in
maxillary bone mass recovery between the two sodium
alendronate dosages used (Table 3).
It has been reported that alendronate administration in
normal rats significantly reduces orthodontic movement.4 It
has been also demonstrated that individuals under alendro-
nate treatment for longer periods of time have lesser tooth
movement rates, which hampers orthodontic treat-
ment.12,13,38 In the present rat model study, that simulates
osteoporosis treatment with bisphosphonate (in a short period
of time), we found no significant difference of tooth movement
in comparison to the control group, although the data reveal a
tendency towards a lesser movement in the groups treated
with ALN. With time, bisphosphonate molecules become
incorporated into the bone matrix, slowing the turnover
process and requiring more time for the organization of the
bone tissue due to the inhibition of osteoclastic activity.39
Therefore, individuals under treatment with ALN need longer
reactivation times for the dissipation of the force to occur.
Otherwise, large hyalinized areas could occur due to the
accumulation of forces on the periodontal ligament, leading to
root resorption.In a recent study involving teriparatide, no difference in
tooth movement was found between treated and untreated
ovariectomized rats.14 While this medication is also used for
the control of bone turnover in osteopenic and osteoporotic
states, teriparatide acts by increasing osteoblastic activity and
therefore does not act directly on osteoclasis, which is
accelerated, thereby allowing greater tooth movement in both
treated and untreated ovariectomized rats.14 Due to the
possibility of accelerating orthodontic movement while
treating osteopenia/osteoporosis, the study cited suggests
that teriparatide could be used as an alternative to bispho-
sphonates.
In the present study the ovarectomized rats taking both
dosages of alendronate underwent less orthodontic move-
ment than controls. However no statistical differences were
found. Thus, we can expect close to normal orthodontic
movement in individuals that have been treated with
alendronate for a short period of time, but we may still be
concerned about long-term alendronate treated patients.12
As the loss of bone mass affects the maxilla, orthodontists
should determine whether the patient is on medication aimed
at controlling bone turnover and ascertain the duration of
such treatment, since these drugs can exert an effect on the
duration and outcome of orthodontic treatment.
5. Conclusion
The administration of alendronate reduced tooth movement
in ovariectomized groups when compared to the untreated
ovariectomized group. No detectable difference was found
between the two dosages used in this study.
Tooth movement in ovariectomized rats treated with
alendronate was also smaller than control non-ovariecto-
mized rats, however without statistical difference.
Funding
This work was supported by CAPES (Coordenac¸a˜o de Aperfei-
c¸oamento de Pessoal de Nı´vel Superior).
Conflicts of interest
None declared.
Ethical approval
The procedures employed in this study were approved by
UNESP (Universidade Estadual Paulista) and the Ethics
Committee on Animal Experimentation under process num-
ber 2011-03696.
Acknowledgements
This work was supported by CAPES (Coordenac¸a˜o de Aperfei-
c¸oamento de Pessoal de Nı´vel Superior).
a r c h i v e s o f o r a l b i o l o g y 6 0 ( 2 0 1 5 ) 7 7 6 – 7 8 1 781r e f e r e n c e s
1. Brudvik P, Rygh P. Multinucleated cells remove the main
hyalinized tissue and start resorption of adjacent root
surfaces. Eur J Orthod 1994;16:265–73.
2. Davidovitch Z. Tooth movement. Crit Rev Oral Biol Med
1991;2:411–50.
3. Choi J, Baek SH, Lee J, Chang Y. Effects of clodronate on early
alveolar bone remodeling and root resorption related to
orthodontic forces: a histomorphometric analysis. Am J
Orthod Dentofacial Orthop 2010;138. 548.e1–548.e8.
4. Karras JC, Miller JR, Hodges JS, Beyer JP, Larson BE. Effect of
alendronate on orthodontic tooth movement in rats. Am J
Orthod Dentofacial Orthop 2009;136:843–7.
5. Rosen CJ, Bilezikian JP. Anabolic therapy for osteoporosis.
J Clin Endocrinol Metab 2001;86:957–64.
6. Iwamoto J, Miyata A, Sato Y, Takeda T, Matsumoto H. Five-
year alendronate treatment outcome in older
postmenopausal Japanese women with osteoporosis or
osteopenia and clinical risk factors for fractures. Ther Clin
Risk Manag 2009;5:773–9.
7. Lerner UH. Bone remodeling in post-menopausal
osteoporosis. J Dent Res 2006;85:584–95.
8. Kimmel DB. Mechanisms of action, pharmacokinetic and
pharmacodynamic profile, and clinical applications of
nitrogen containing biphosphonates. J Dent Res
2007;86:1022–33.
9. Flanagan AM, Chambers TJ. Inhibition of bone resorption by
bisphosphonates: interactions between bisphosphonats,
osteoclasts, and bone. Calcif Tissue Int 1991;49:407–15.
10. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman
GD, et al. Bisphosphonates promote apoptosis in murine
osteoclasts in vitro and in vivo. J Bone Miner Res
1995;10:1478–87.
11. Russel RGG, Rogers MJ. Bisphosphonates: from the
laboratory to the clinic and back again. Bone 1999;25:97–106.
12. Zahrowski JJ. Bisphosphonate treatment: an orthodontic
concern calling for a proactive approach. Am J Orthod
Dentofacial Orthop 2007;131:311–20.
13. Rinchuse DJ, Rinchuse DJ, Sosovicka MF, Robison JM,
Pendleton R. Orthodontic treatment of patients using
bisphosphonates: a report of 2 cases. Am J Orthod Dentofacial
Orthop 2007;131:321–6.
14. Salazar M, Hernandes L, Ramos AL, Micheletti KR, Albino
CC, Cuman RKN. Effect of teriparatide on induced teeth
displacement in ovariectomized rats: a histomorphometric
analysis. Am J Orthod Dentofacial Orthop 2011;139:e337–44.
15. Consolaro A, Martins-Ortiz MF. Reabsorc¸o˜es denta´rias nas
especialidades clı´nicas. 1st ed. Maringa´: Dental Press; 2005:
493–521.
16. Heller IJ, Nanda R. Effect of metabolic alteration of
periodontal fibers on orthodontic tooth movement. An
experimental study. Am J Orthod 1979;75:239–58.
17. Ren Y, Maltha JC, Kuijpers-Jagtman AM. Optimum force
magnitude for orthodontic tooth movement: a systematic
literature review. Angle Orthod 2003;73:86–92.
18. Maganzini AL, Wong AM, Ahmed MK. Forces of various nickel
titanium closed coil springs. Angle Orthod 2010;80:182–7.
19. Gameiro GH, Nouer DF, Pereira Neto JS, Siqueira VC,
Andrade ED, Novaes PD, et al. Effects of short- and long-
term celecoxib on orthodontic tooth movement. Angle
Orthod 2008;78:860–5.
20. Akin E, Gurton AU, Olmez H. Effects of nitric oxide in
orthodontic tooth movement in rats. Am J Orthod Dentofacial
Orthop 2004;126:608–14.21. Ren Y, Maltha JC, Kuijpers-Jagtman AM. The rat as a model
for orthodontic tooth movement: a critical review and a
proposed solution. Eur J Orthod 2004;26:483–90.
22. Yokoya K, Sasaki T, Shibasaki Y. Distributional changes of
osteoclasts and pre-osteoclasts cells in periodontal tissues
during experimental tooth movement as revealed by
quantitative immunohistochemistry of H+-ATPase. J Dent
Res 1997;76(1):580–7.
23. Hernandes L, Ramos AL, Micheletti KR, Santi AP, Cuoghi OA,
Salazar M. Densitometry, radiography, and
histological assessment of collagen as methods to evaluate
femoral bones in an experimental model of osteoporosis.
Osteoporos Int 2011. http://dx.doi.org/10.1007/s00198-011-
1539-82011.
24. Porter G. The UFAW handbook on the care and management of
laboratory animals. 3rd ed. Livingstone: Worden NA; 1967:
353–90.
25. Noda K, Nakamura Y, Kogure K, Nomura Y. Morphological
changes in the rat periodontal ligament and its vascularity
after experimental tooth movement using superelastic
forces. Eur J Orthod 2009;31:37–45.
26. Gonzales C, Hotokezaka H, Yoshimatsu M, Yozgatian J,
Darendeliler MA, Yoshida N. Force magnitude and duration
effects on amount of tooth movement and root resorption
in the rat molar. Angle Orthod 2008;78:502–9.
27. Miura F, Mogi M, Ohura Y, Karibe M. The super-elastic
Japanese NiTi alloy wire for use in orthodontics. Part III.
Studies on Japanese NiTi alloy coil springs. Am J Orthod
Dentofacial Orthop 1988;94:89–96.
28. Gianelly AA, Bednar J, Dietz VS. Japanese NiTi coils used to
move molars distally. Am J Orthod Dentofacial Orthop
1991;99:564–6.
29. Newman E, Turner AS, Wark JD. The potential of sheep for
the study of osteopenia: current status and comparison
with other animal models. Bone 1995;16:277–84.
30. Tanaka M, Ejiri S, Toyooka E, Kohno S, Ozawa H. Effects of
ovariectomy on trabecular structures of rat alveolar bone.
J Periodontal Res 2001;37:161–5.
31. Shirai H, Sato T, Oka M, Hara T, Mori S. Effect of calcium
supplementation on bone dynamics of the maxilla,
mandible and proximal tibia in experimental osteoporosis.
J Oral Rehabil 2001;29:287–94.
32. Chen Y, Heiman ML. Increased weight gain after
ovariectomy is not a consequence of leptin resistance. Am J
Physiol Endocrinol Metab 2001;280:E315–22.
33. Yoneda N, Saito S, Kimura M, Yamada M, Iida M, Murakani
T, et al. The influence of ovariectomy on ob gene expression
in rats. Horm Metab Res 1998;30:263–5.
34. Jee WSS, Yao W. Overview: animal models of osteopenia
and osteoporosis. J Musculoskelet Neuron Interact 2001;1:
193–207.
35. Rodan GA, Fleisch HA. Bisphosphonates: mechanisms
of action (Perspectives). J Clin Invest 1996;97:2692–6.
36. Licata AA. Discovery, clinical development, and
therapeutic uses of bisphosphonates. Ann Pharmacother
2005;39:668–77.
37. Haddad PT, Salazar M, Hernandes L. Histomorphometry
of the organic matrix of the femur in ovariectomized rats
treated with sodium alendronate. Rev Bras Ortop 2014. http://
dx.doi.org/10.1016/j.rbo.2014.01.021.
38. Igarashi K, Mitani H, Adachi H, Shinoda H. Anchorage and
retentive effects of a bisphosphonate (AHBuBP) on tooth
movements in rats. Am J Orthod Dentofacial Orthop
1994;106:279–89.
39. Rodan GA. Bisphosphonates: mechanisms of action. Endocr
Rev 1998;19:80–100.
